Healio14d
Targeted therapies for breast cancer increase thrombosis risk
The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...
The Lancet20d
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial
aDivision of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada bDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine ...
Frontiers27d
Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
The present study intends to comprehensively compare the efficacy and safety of various anticoagulants in VTE. Methods: Medline, Embase, and Cochrane Library from their inception up to August 2023 ...
Medscape27d
Pharmacologic Prophylaxis Against Venous Thromboembolism in Hospitalized Patients With Cirrhosis and Associated Coagulopathies
Although VTE prophylaxis was provided in some of the evaluated cases, the study was not designed to ascertain the effects of prophylaxis on the risk of VTE. In 2008, Gulley and associates [5 ...
Medscape2y
Development and Implementation of a Program to Assess Medical Patients' Need for Venous Thromboembolism Prophylaxis
Purpose: The development and implementation of a program to assess medical patients' need for venous thromboembolism (VTE) prophylaxis are described. Summary: The pharmacy services, medicine, and ...
ahajournals.org16y
The Epidemiology of Venous Thromboembolism in the Community
Among patients hospitalized for acute medical illness, active cancer is a major venous thromboembolism risk factor. After controlling for cancer, additional independent risk factors for venous ...